Cassava Sciences, Inc. (SAVA)

Cassava Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	121.14	201.02	233.44	93.51	23.08
Cash & Cash Equivalents	121.14	201.02	233.44	93.51	23.08
Cash Growth	-39.74%	-13.89%	149.65%	305.12%	16.53%
Other Current Assets	8.5	10.21	11.05	0.49	0.27
Total Current Assets	129.63	211.23	244.48	93.99	23.35
Property, Plant & Equipment	21.85	22.99	20.83	0.31	0.14
Goodwill and Intangibles	0.18	0.62	1.08	0	0
Other Long-Term Assets	0	0	0.4	0	0
Total Long-Term Assets	22.03	23.61	22.3	0.31	0.14
Total Assets	151.66	234.83	266.78	94.3	23.49
Accounts Payable	10.57	4.02	7.13	0.91	0.45
Current Debt	0	0.1	0.1	0.06	0.09
Other Current Liabilities	3.62	2.94	5.31	0.9	0.84
Total Current Liabilities	14.2	7.06	12.53	1.87	1.39
Long-Term Debt	0	0.04	0.14	0.24	0
Other Long-Term Liabilities	0	0.2	0.19	0	0
Total Long-Term Liabilities	0	0.23	0.33	0.24	0
Total Liabilities	14.2	7.3	12.87	2.1	1.39
Total Debt	0	0.14	0.24	0.29	0.09
Debt Growth	-	-41.10%	-19.45%	225.56%	-
Retained Earnings	-380.77	-283.55	-207.31	-174.92	-168.59
Shareholders' Equity	137.47	227.54	253.92	92.2	22.1
Net Cash / Debt	121.14	200.88	233.2	93.21	22.99
Net Cash / Debt Growth	-39.70%	-13.86%	150.18%	305.43%	16.08%
Net Cash Per Share	2.89	5.00	5.92	3.57	1.32
Working Capital	115.44	204.16	231.95	92.13	21.96
Book Value Per Share	3.28	5.66	6.44	3.53	1.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).